Temporal Shifting of Influenza Subtype Dynamics in Pakistan Following the COVID‐19 Pandemic: A 10‐Year FluNet Analysis, 2015–2024
Open Access
- 1 November 2026
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (11) , e70341
Abstract
Background: The COVID‐19 pandemic and associated nonpharmaceutical interventions caused unprecedented suppression of influenza circulation globally. Pakistan, with its high population density and evolving surveillance capacity, lacks long‐term data on post‐COVID‐19 influenza patterns, essential for guiding vaccine policy. Methods: We extracted weekly virological data for Pakistan from the WHO FluNet platform (January 1, 2015, to December 31, 2024). The study period was divided into pre‐COVID‐19 (2015–2019), COVID‐19 disruption (2020–2021), and post‐COVID‐19 (2022–2024) phases. Outcomes included type A versus B proportion, subtype distribution (A[H1N1]pdm09 vs. A[H3]), positivity, peak intensity, and season duration (weeks with positivity ≥ 10%). Statistical comparisons used chi‐square for subtype distribution and Kruskal–Wallis for peak intensity. Results: We analyzed 6522 positive specimens from 79,484 tested (10,781 pre‐COVID‐19; 14,687 during COVID‐19 disruption; 54,016 post‐COVID‐19). Influenza A declined from 94.2% to 71.7% then rose to 77.5%; influenza B increased from 5.7% to 28.3%, remaining at 22.5% ( p < 0.001). A(H3) dominated during the COVID‐19 disruption (98.8%); A(H1N1)pdm09 regained dominance post‐COVID‐19 (58.8%), though A(H3) remained higher than pre‐COVID‐19 (41.2% vs. 33.3%). Peak intensity differed ( p = 0.047): pre‐COVID‐19 33.3%–67.6%; COVID‐19 disruption 14.0%–17.6%; and post‐COVID‐19 19.8%–37.8%. Season duration was 1 week in 2020 and 3 non‐consecutive weeks in 2021, versus 10–16 weeks pre‐COVID‐19, recovering to 7–13 weeks post‐COVID‐19. Conclusion: The COVID‐19 pandemic induced a lasting shift in Pakistan's influenza epidemiology, with persistently elevated influenza B and reshaped A subtype balance. These findings are consistent with the global disappearance of B/Yamagata and support consideration of trivalent vaccine formulations, though antigenic and genetic data remain necessary to confirm vaccine match.Keywords
This publication has 9 references indexed in Scilit:
- Tracking Respiratory Viruses in Pakistan (2022–2025): Genomic and Epidemiologic Insights from Sentinel Surveillance of Influenza, SARS-CoV-2, and RSVViruses, 2025
- Seasonality of Influenza and Optimizing Timing of Vaccination: Systematic Review and Meta-AnalysisCureus, 2025
- Epidemiological and genomic surveillance of influenza A virus (pdm09 H1N1 and H3N2) strains from 2017 to 2025 in Tianjin, ChinaVirologica Sinica, 2025
- Assessing influenza activity variations in the Asian region during the pre- and post-pandemic period (2017–2023)PLOS ONE, 2025
- Evolutionary analysis of seasonal influenza A viruses in Pakistan 2020–2023Influenza and Other Respiratory Viruses, 2024
- Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021MMWR. Morbidity and Mortality Weekly Report, 2021
- The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infectionsProceedings of the National Academy of Sciences, 2020
- Epidemiology of Influenza among patients with influenza‐like illness and severe acute respiratory illness in Pakistan: A 10‐year surveillance study 2008‐17Journal of Medical Virology, 2020
- Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern AsiaBulletin of the World Health Organization, 2014